Comparison of trinitroglycerin and adenosine as provocative agents for head-up tilt test in patients with unexplained syncope: a semi-crossover randomized clinical trial with prospective follow-up
暂无分享,去创建一个
B. Rahimi | S. Sadeghian | S. H. Mortazavi | D. Soltani | A. Aminorroaya | A. Bozorgi | A. Vasheghani Farahani | Masih Tajdini | Mehdi Easapour Moghadam
[1] Oral Communications , 2009, 2022 21st International Symposium on Parallel and Distributed Computing (ISPDC).
[2] S. Abbasi,et al. The Tehran Heart Center. , 2018, European heart journal.
[3] P. Mitro,et al. Gene Polymorphism of the Adenosine A2a Receptor in Patients with Vasovagal Syncope , 2016, Pacing and clinical electrophysiology : PACE.
[4] J. Deharo,et al. Adenosine and Clinical Forms of Neurally-Mediated Syncope. , 2015, Journal of the American College of Cardiology.
[5] C. Pappone,et al. The use of adenosine and adenosine triphosphate testing in the diagnosis, risk stratification and management of patients with syncope: current evidence and future perspectives. , 2015, International journal of cardiology.
[6] M. Kawamura,et al. Characteristics of head‐up tilt testing with additional adenosine compared with head‐up tilt testing with isoproterenol and isosorbide dinitrate , 2014 .
[7] C. Berry,et al. Adenosine: physiology, pharmacology, and clinical applications. , 2014, JACC. Cardiovascular interventions.
[8] C. Forleo,et al. Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis. , 2013, International journal of cardiology.
[9] J. Deharo,et al. Syncope without prodromes in patients with normal heart and normal electrocardiogram: a distinct entity. , 2013, Journal of the American College of Cardiology.
[10] J. Deharo,et al. A2A adenosine receptor function in patients with vasovagal syncope. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[11] J. Deharo,et al. Adenosine plasma level and A2A adenosine receptor expression: correlation with laboratory tests in patients with neurally mediated syncope , 2012, Heart.
[12] I. Holme,et al. Risk factors for unexpected sudden death in patients with non-symptomatic aortic stenosis (the SEAS study) , 2010 .
[13] R. Faria,et al. Positioning of the egc leads in Brugada Syndrome: higher sensitivy with lower specificity? Answers from a genetically characterized family , 2009 .
[14] S. Lévy,et al. Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism. , 2009, European heart journal.
[15] S. Lévy,et al. Increased expression of adenosine A2A receptors in patients with spontaneous and head-up-tilt-induced syncope. , 2006, Heart rhythm.
[16] P. Mitro,et al. Diagnostic yield of adenosine and nitroglycerine stimulated tilt test in patients with unexplained syncope. , 2007, Bratislavske lekarske listy.
[17] A. N. Sulke,et al. A randomised prospective comparison of three protocols for head-up tilt testing and carotid sinus massage. , 2005, International journal of cardiology.
[18] S. Markowitz,et al. Single‐Stage Adenosine Tilt Testing in Patients with Unexplained Syncope , 2004, Journal of cardiovascular electrophysiology.
[19] S. Lévy,et al. Role of Endogenous Adenosine as a Modulator of Syncope Induced During Tilt Testing , 2002, Circulation.
[20] S. Markowitz,et al. Clinical utility of an adenosine-nitroglycerin tilt test protocol , 2002 .
[21] M. Brignole,et al. Clinical features of adenosine sensitive syncope and tilt induced vasovagal syncope , 2000, Heart.
[22] W. Shen,et al. Vasovagal syncope. , 2000, Annals of internal medicine.
[23] W. Shen,et al. Vasovagal Syncope , 2000, Annals of Internal Medicine.
[24] M. Brignole,et al. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study. , 2000, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[25] S. Markowitz,et al. Induction of neurally mediated syncope with adenosine. , 1999, Circulation.
[26] J. Shryock,et al. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. , 1997, The American journal of cardiology.
[27] K. Bailey,et al. Adenosine: potential modulator for vasovagal syncope. , 1996, Journal of the American College of Cardiology.
[28] S. Su,et al. Excessive myocardial contraction in vasovagal syncope demonstrated by echocardiography during head‐up tilt test , 1996, Clinical cardiology.
[29] T. Iwamoto,et al. Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells. , 1994, Biochemical and biophysical research communications.
[30] M Akhtar,et al. Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head-up tilt. , 1991, Journal of the American College of Cardiology.
[31] T. J. Killian,et al. Adenosine Increases Sympathetic Nerve Traffic in Humans , 1991, Circulation.
[32] L. Arroyo,et al. 2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor. , 1991, Journal of medicinal chemistry.
[33] I. Biaggioni,et al. Cardiovascular and Respiratory Effects of Adenosine in Conscious Man: Evidence for Chemoreceptor Activation , 1987, Circulation research.
[34] E. Jackson. Role of adenosine in noradrenergic neurotransmission in spontaneously hypertensive rats. , 1987, The American journal of physiology.
[35] R. Berne,et al. Release of Adenosine from Ischemic Brain: Effect on Cerebral Vascular Resistance and Incorporation into Cerebral Adenine Nucleotides , 1974 .